RSS   Newsletter   Contact   Advertise with us
Post Online Media

resTORbio appoints Joan Mannick as CMO

Joan MannickresTORbio, a subsidiary of PureTech Health biopharmaceuticals companys, announced the appointment of Joan Mannick as chief medical officer.

Dr. Mannick joins resTORbio from Novartis, where she led the clinical program that targets pathways regulating aging to treat aging-related conditions.

Prior to joining Novartis in 2010, Dr. Mannick was a Medical Director at Genzyme working in multiple therapeutic areas.

Prior to Genzyme, Dr. Mannick was a faculty member at Harvard Medical School and University of Massachusetts Medical School.

Dr. Mannick received her A.B. from Harvard College and her M.D. from Harvard Medical School.

She completed her residency in Internal Medicine at Brigham and Women’s Hospital and an Infectious Disease fellowship as part of the Harvard Combined Infectious Disease Program.

 LATEST MOVES FROM Massachusetts 

More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy